Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Wrist and Hand Braces
... reach US$500.7 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. The U.S. Market is Estimated at US$86.7 Million While China is Forecast to Grow at 9.4% CAGR The Wrist ... Read More
-
Eye Allergy Therapeutics
... by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the ... Read More
-
Neuroprosthetics
... of 12.0% over the analysis period 2023-2030. Motor Neuron Disorders Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$15.8 Billion by the end of the ... Read More
-
Spinal Trauma Devices
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Internal Fixation Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$4.9 Billion ... Read More
-
Spinal Muscular Atrophy
... by 2030, growing at a CAGR of 12.3% over the analysis period 2023-2030. Type 1 Spinal Muscular Atrophy, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach ... Read More
-
Addiction Treatment
... at a CAGR of 4.8% over the analysis period 2023-2030. Alcohol Addiction Treatment, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.0 Billion by the end ... Read More
-
Substance Abuse Treatment
... by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Nicotine Addiction Treatment, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$9.4 Billion ... Read More
-
Neurology Devices
... at a CAGR of 5.9% over the analysis period 2023-2030. Cerebrospinal Fluid Management Devices, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$7.1 Billion by the ... Read More
-
Ophthalmic Femtosecond Lasers
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million ... Read More
-
Breakthrough Therapy (BT) Designation
... reach US$415.7 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach ... Read More
-
Global Malignant Pleural Mesothelioma Market (2024 Edition): Analysis By Drug Type (Pemetrexed and Combination, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Other Drug Types), By Route of Administration, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Forecast (2020-2030) Executive Summary Azoth Analytics has released a research report titled “Global Malignant Pleural Mesothelioma Market (2024 Edition)” which provides a Pemetrexed and Combination analysis of the Global Malignant Pleural Mesothelioma industry in terms ... Read More
-
Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide The ... Read More
-
Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Epilepsy, Obsessive Compulsive Disorder, Dystonia, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing ... Read More
-
Rheumatology Therapeutics
... CAGR of 3.1% over the analysis period 2023-2030. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$51.3 Billion by the end ... Read More
-
Small Bone and Joint Orthopedic Devices
... reach US$20.4 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Fracture Fixation & Replacement Systems, one of the segments analyzed in the report, is expected to record a 7.8% ... Read More
-
Aesthetic Ophthalmology Devices
... at a CAGR of 7.8% over the analysis period 2023-2030. Cosmetic Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$432.0 Million by the end ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices
... reach US$37.9 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Dental Fluoride Treatment
... at a CAGR of 5.1% over the analysis period 2023-2030. Toothpaste, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Infectious Disease Therapeutics
... at a CAGR of 7.1% over the analysis period 2023-2030. HIV Disease Therapeutics, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$113.7 Billion by the end ... Read More
-
Intracranial Pressure (ICP) Monitoring Devices
... Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Invasive Technique, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.4 Billion ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.3% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Cosmetic Dentistry
... CAGR of 6.1% over the analysis period 2023-2030. Dental Systems & Equipment, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$14.2 Billion by the end of ... Read More
-
Erectile Dysfunction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Clinics, Ambulatory Surgical Centers (ASC), and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to growing prevalence of erectile ... Read More
-
Heart Valve Repair and Replacement Devices
... the year 2023, is expected to reach US$43.1 Billion by 2030, growing at a CAGR of 16.0% over the analysis period 2023-2030. Replacement Devices Application, one of the segments analyzed in the report, is expected ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the ... Read More
Research Assistance
